Connect Biopharma Holdings Limited
CNTB
$2.45
-$0.23-8.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.65% | -33.58% | -186.88% | -18.16% | 43.69% |
| Total Depreciation and Amortization | 14.56% | 1.70% | 5.56% | 5.49% | 48.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.05% | -63.18% | -66.50% | -40.75% | 5.09% |
| Change in Net Operating Assets | -41.37% | 51.54% | 97.87% | -108.75% | -18.11% |
| Cash from Operations | -385.12% | -33.82% | -63.63% | -1,585.11% | 72.04% |
| Capital Expenditure | 94.89% | 76.87% | -4.48% | -- | -400.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 171.19% | -- | 55.20% | -322.29% | -175.96% |
| Cash from Investing | 169.68% | 9,859.18% | 59.78% | -323.15% | -177.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 574.53% | -- | 33.06% | -- | 821.74% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 574.53% | -- | 33.06% | -- | 26.95% |
| Foreign Exchange rate Adjustments | 105.19% | -88.56% | 119.61% | 133.94% | -452.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.64% | 77.96% | -66.05% | -461.73% | -257.23% |